2004
$17M
from 6 investors over 6 rounds
Neuraltus Pharmaceuticals raised $15M on May 24, 2016
Investors: VantagePoint Venture Partners
Neuraltus Pharmaceuticals raised $1.5M on April 1, 2012
Investors: Adams Street Partners
Neuraltus Pharmaceuticals raised $9.6M on January 31, 2012
Investors: Adams Street Partners and VantagePoint Venture Partners
Neuraltus Pharmaceuticals raised $17M on March 26, 2009
Investors: VantagePoint Venture Partners and Adams Street Partners